Author

R.E. Buller

Observed names: R Buller, R E Buller, R. Buller, R. E. Buller, RE Buller, RICHARD E. BULLER

Observed institutions: University of Iowa, Cleveland Clinic, Virginia Mason Medical Center, UW Health University Hospital, University of Iowa Hospitals and Clinics, Abington Memorial Hospital, University of Oklahoma

OpenAlex ID: A5111777258

Extraovarian peritoneal serous papillary carcinoma: A case‐control retrospective comparison to papillary adenocarcinoma of the ovary

1994 · J.D. Bloss, S.‐Y. Liao, et al. · International Journal of Gynecology & Obstetrics · 23

Indiana pouch continent urinary reservoir in patients with previous pelvic irradiation

1990 · RS Mannel, PS Braly, et al. · International Journal of Gynecology & Obstetrics · 17

The significance of peritoneal cytology in stage IB cervical cancer.

1992 · P C Morris, J Haugen, et al. · PubMed · 16

A phase II, open-label study of ispinesib (SB-715992) in patients with platinum/taxane refractory or resistant relapsed ovarian cancer

2007 · M. S. Shahin, P. Braly, et al. · Journal of Clinical Oncology · 14

Conseusus statements on prognostic factors in epithelial ovarian carcinoma. Report of the Consensus Meeting organized by the European Society of Gynaecological Oncology, ESGO.

2000 · P Bösze, R C Bast, et al. · PubMed · 13

RESPONSE: Re: Association Between Nonrandom X-Chromosome Inactivation and BRCA1 Mutation in Germline DNA of Patients With Ovarian Cancer

1999 · R. E. Buller, A. K. Sood, et al. · JNCI Journal of the National Cancer Institute · 5

Estrogen Replacement Therapy in Endometrial and Breast Cancer Survivors

1999 · VIKAS MAHAVNI, RICHARD E. BULLER · Clinical Obstetrics & Gynecology · 2

97 POSTER Analysis of EGFR and KRAS mutations in circulating tumor DNA (cTDNA) from plasma of NSCLC patients in phase 2 trials of XL647

2008 · F. Schimmoller, N.A. Rizvi, et al. · European Journal of Cancer Supplements · 1

The Clinical Course of Cervical Carcinoma In Situ Diagnosed During Pregnancy

1998 · A Coppola, J Sorosky, et al. · Journal of Lower Genital Tract Disease · 1

26 Patient Selection Markers for Anti-angiogenic Agents in Metastatic Renal Cell Carcinoma: Dream or Reality?

2012 · P.A. English, J.A. Williams, et al. · European Journal of Cancer

332 INVITED Registration-Directed Co-Development of Biomarkers and Therapeutics

2011 · R. Buller, H. Sakul, et al. · European Journal of Cancer

CA-125 kinetics and ovarian cancer survival

1991 · R. Buller, M. Berman, et al. · Gynecologic Oncology

Works count: 12

Citation count: 92

H-index: 5

I10-index: 5